pamapimod

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2010
02420082010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The development of a new series of p38α inhibitors resulted in the identification of two clinical candidates, one of which was… (More)
Is this relevant?
2011
2011
OBJECTIVE This study investigated the pharmacokinetics, excretion, and metabolism of pamapimod following a single oral dose in… (More)
Is this relevant?
2010
2010
OBJECTIVE To determine the efficacy and safety of pamapimod in adult patients with active rheumatoid arthritis (RA) who had an… (More)
Is this relevant?
2010
2010
This study evaluated the potential pharmacokinetic interaction of pamapimod, a p38 mitogen-activated protein kinase inhibitor… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2010
Review
2010
Methotrexate alone or in combination with other agents is the standard treatment for moderate-to-severe rheumatoid arthritis. As… (More)
Is this relevant?
2010
2010
BACKGROUND AND PURPOSE A main challenge in the therapy of osteoarthritis (OA) is the development of drugs that will modify the… (More)
Is this relevant?
2009
2009
OBJECTIVE To determine the efficacy and safety of pamapimod (a selective inhibitor of the alpha-isoform of p38 MAP kinase) as… (More)
Is this relevant?
2009
2009
 
Is this relevant?
2008
2008
P38alpha is a protein kinase that regulates the expression of inflammatory cytokines, suggesting a role in the pathogenesis of… (More)
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Is this relevant?